top of page
Image-empty-state_edited.jpg

CLICK

CLICK Preferred Equity 1
Creator of mouth spray products for the new-age cannabis consumer

?/100

Crowd Score
There is a newer open investment round for this company - click here to view
Our take:
Branding isn't yet a differentiator in the cannabis space, but as the market grows into new states there is a good opportunity for a brand to make a market presence - the company just signed a 5 year brand agreement with Mike Tyson which will help in this regard.

Thanks, catch you soon!

Sign up to receive weekly deal alerts and top news

Round Performance

Amount Raised

[]

Average-Investment-Icon-p-1600.png
Average Investment

[]

Average-Daily-Investment-Icon-p-1600.png
Average Per Day

[]

Investors-Icon-p-1600.png
# of Investors

[]

Investors vs. Capital Raised

Investment Type

Preferred Stock

Round Valuation

$20,000,000

Minimum Investment

$1,000

Price Per Share

$undefined

Investment Details

Early Bird Perks

Perk description
Perk level (dollars)
Perk level (days)
Loading...

No early bird perks for this round!

Screen Shot 2020-07-15 at 12.01.28 PM.pn

View early bird perks, company financials, valuation methods, and more

Similar Investments

Image-empty-state_edited.jpg
FOCUS V
Common Stock
Image-empty-state_edited.jpg
REEF GROWS
Convertible Note
Image-empty-state_edited.jpg
Calyxeum
Revenue Share

© 2023 Crowdonomics

  • Black Facebook Icon
  • Black Twitter Icon
  • Instagram

Proudly made in Cincinnati, Ohio

Crowdonomics is not a registered broker-dealer or investment adviser. The investments identified on the Crowdonomics website may not be purchased through Crowdonomics; rather, all transactions will be directly between you and the third-party platform hosting the applicable investment. The information contained herein regarding available investments is obtained from third party sources. While Crowdonomics generally considers such sources to be reliable, Crowdonomics does not represent that such information is accurate or complete, and Crowdonomics has not undertaken any independent review of all information and provides it on an as-is basis.

bottom of page